Loading...
XTAI
4104
Market cap447mUSD
Dec 05, Last price  
81.60TWD
1D
0.00%
1Q
-7.38%
Jan 2017
111.51%
IPO
57.99%
Name

Excelsior Medical Co Ltd

Chart & Performance

D1W1MN
XTAI:4104 chart
P/E
18.15
P/S
1.64
EPS
4.50
Div Yield, %
4.66%
Shrs. gr., 5y
2.92%
Rev. gr., 5y
5.75%
Revenues
8.54b
+3.71%
14,300,782,00015,355,606,0005,994,336,0005,998,988,0005,740,961,0005,806,677,0006,202,884,0006,205,758,0006,095,337,0006,345,031,0006,457,362,0006,675,494,0006,573,152,0007,186,828,0008,233,404,0008,538,546,000
Net income
771m
+3.30%
311,950,000355,692,000333,970,000275,785,000299,942,000285,681,000379,000,000389,557,000399,047,000451,562,000514,755,000571,670,000607,149,000667,453,000746,605,000771,259,000
CFO
2.47b
+2,207.58%
693,512,000-33,458,000-528,524,000717,257,000357,477,000736,736,000739,959,000449,713,000-487,388,000192,434,0001,194,496,000869,433,000945,049,000637,126,000107,101,0002,471,445,000
Dividend
Apr 19, 20243.8 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Excelsior Medical Co., Ltd. distributes medical related systems in Taiwan, China, Japan, Korea, Malaysia, and the Philippines. The company offers equipment for hemodialysis, regular drug used in the medical institution, surgical equipment, and medical assistant electronics; and cosmetic equipment. It also provides medical administration services for single department. The company was founded in 1988 and is based in New Taipei City, Taiwan.
IPO date
Jun 08, 2001
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT